Join CBSET at the MDG Forum: Combination Products Medical Device Advances and Opportunities, October 30, 2018, at the Fine Arts Center at Regis College, 235 Wellesley St, Weston, MA.
The topic of this forum will be 21st century drug development and unmet needs. Some of Boston’s most innovative companies will describe advances in drug delivery strategies in preclinical drug discovery and development.
If you would like to meet up with us at the event, please contact David Parrillo, Sr. Account Executive at CBSET.
Related CBSET Services:
- CBSET GLP Preclinical Services
- Localized/Targeted Drug Delivery
- Computational Modeling of Local Drug Delivery
- Cell-Based Therapies
World Pharma Today, Cell-based Therapy and FDA Review: Partnering for Success at Your pre-IND Meeting
by Michael Naimark, MS, Director of Business Development at CBSET, Inc.
Defining drug and target protein distributions after stent-based drug release: Durable versus deployable coatings. by Tzafriri AR, Garcia-Polite F, Li X, Keating J, Balaguer JM, Zani B, Bailey L, Markham P, Kiorpes TC, Carlyle W, Edelman ER. Journal of Controlled Release, March 28, 2018, Volume 274, Pages 102-108.
Intracochlear Drug Delivery Systems: A Novel Approach Whose Time Has Come. Peppi M, Marie A, Belline C, Borenstein JT. Expert Opinion on Drug Delivery, Volume 15, Issue 4, March 9, 2018, Pages 319-324.
A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma. Indolfi L, Ligorio M, Ting DT, Xega K, Tzafriri AR, Bersani F, Aceto N, Thapar V, Fuchs BC, Deshpande V, Baker AB, Ferrone CR, Haber DA, Langer R, Clark JW, Edelman ER. Biomaterials, Volume 93, July 2016, Pages 71-82.